DCGI Issues Drug Alert On Usage Of Cough And Cold Medicine Pholcodine
New Delhi : The Drugs Controller General (India) (DCGI) has issued an advisory to the doctors, healthcare professionals and consumers to stop usage of opioid medicine pholcodine, which is used in…
DCGI Warns Of Stringent Action For Quality Lapses As International Community Started Doubting Indian Drugs
Chennai : Hailing the stellar performance of the Indian pharmaceutical industry on one side but raising quality concerns on the other in the wake of quality alerts issued by WHO on…
TS Pharma Firm Penalised Rs 45 Lakh For Pollution
Hyderabad: The Telangana State Pollution Control Board (TSPCB) has imposed an environmental compensation penalty of Rs 45 lakh on Brundavan Laboratories, a pharmaceutical company, for violating environmental regulations. The pharmaceutical…
Exports Of Medical Devices Grew 16 Per Cent In 2022-23: AiMeD
New Delhi : India’s exports of medical devices has registered a 16.15 per cent growth during the fiscal year 2022-23 at Rs. 27,818 crore as compared to the Rs. 23,950 crore…
Adulterated Sanitizers: Punjab & Haryana High Court Refuses Pre-Arrest Bail To Accused
Chandigarh : The Punjab & Haryana High Court has refused to grant anticipatory bail to two persons who are alleged to have been involved in manufacturing, sale and distributing hand…
Poisoned Cough Syrup Traced To India Reveals Lapses In Regulation
New Delhi : Ebrima Sagnia was frantic as he carried his son through the doors of a hospital one evening last September. A few days earlier, Lamin had been a rambunctious…
Med stores in Odisha’s Angul sealed for dealing in spurious drugs
CUTTACK: A Special Task Force (STF) of the Drug Enforcement Squad on Thursday sealed Maa Budhi Medicine Store, a retail outlet at Kadampadia and Ganapati Enterprisers, a wholesale medicine firm at…
Medical Devices Regulation To Come Into Force From October 1: DCGI
New Delhi : Medical devices of all four categories (A, B, C, and D) will be brought under the regulation by October 1 and as of now only two groups (A…
FDI equity inflow into pharma sector registers growth of 45% in FY 23 to cross $2 billion mark
The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical industry has registered a growth of 45.4 per cent in the fiscal year ended March, 2023, as compared to the…
